Navigation Links
Neuro Kinetics to Showcase I-Portal® Research at Brain Injury Awareness Day on Capitol Hill
Date:3/15/2011

PITTSBURGH, March 15, 2011 /PRNewswire/ -- Neuro Kinetics, Inc. (NKI) (www.neuro-kinetics.com), manufacturers of noninvasive medical diagnostic equipment used worldwide for neurophysiologic/neurotologic testing, said today that it will showcase its eye-tracking I-Portal® technology and the company's collaborative push with the military to develop earlier diagnosis of combat injuries, at the upcoming 2011 Brain Injury Awareness Day on Capitol Hill in Washington, D.C.

The March 16th event is being organized by the Congressional Brain Injury Task Force, a nonpartisan effort of more than 110 Congressional members to raise awareness of brain injuries afflicting millions of Americans -- including soldiers, athletes and accident victims.

"Clearly, there is great urgency to find more accurate ways to diagnose brain injuries and we support efforts to generate interest among our lawmakers," said J. Howison Schroeder, NKI president and CEO. "The data suggests our I-Portal technology is opening a new door to accurate and timely diagnosis of brain injuries. Research with the military and others shows great promise and we are eager to detail the work to members of Congress and their staffs."

NKI currently is involved in collaborative research projects at a number of U.S. military medical facilities to develop and verify a new battery of eye-tracking neurotologic/neurophysiologic tests for earlier and more accurate diagnosis of Traumatic Brain Injury (TBI) and mild TBI.

An estimated 20 percent of soldiers returning from Afghanistan and Iraq suffer from TBI or mTBI resulting from bomb blasts.

NKI's research includes collaboration with specialists at the U.S. Army Aeromedical Research Laboratory (USAARL) at Fort Rucker, Alabama, and other military facilities, including Tripler Army Medical Center (Hawaii), The Traumatic Brain Injury Warrior Resilience and Recovery Center at Fort Campbell (Kentucky) and Walter Reed Army Medical Center (D.C.).

NKI also is involved in a research effort with a large hospital in Western Pennsylvania to gather data from high school and college athletes, part of an effort to improve diagnosis and treatment of sports concussions.

"The eye is the portal to the brain," Schroeder said. "We believe that we are on the verge of a new era in diagnostic testing for a wider range of medical challenges, including new and better ways to diagnose brain injuries."

ABOUT NEURO KINETICS, INC.

Neuro Kinetics, Inc. (NKI) is the world leader in eye tracking technology and non-invasive neurophysiologic/neurotologic diagnostic testing.

Central to its product mix and technological advances is the premise that the eye is the portal to the brain.  Research has shown the detection of abnormal eye reflexes can indicate the presence of over 200 diseases and medical conditions.

For more than 25 years, NKI has supplied comprehensive diagnostic tools to audiologists, ENT's, neuro-otologists, neuro-ophthalmologists and neurologists around the globe.  The company's patented products include the I-Portal® NOTC (Neuro-Otologic Test Center), I-Portal® VNG (Video Nystagmography) and I-Portal® VOG (Video Oculography), along with related accessories, software, training and support services. MEDIA CONTACTJohn BuckmanBuckman Communications, for Neuro Kinetics, Inc.+ 1 412-381-2900 or jbuckman@buckman.biz
'/>"/>

SOURCE Neuro Kinetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
3. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
4. Callisto Pharmaceuticals Completes Enrollment of Phase II Trial of Atiprimod in Neuroendocrine Cancer
5. Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease
6. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
7. NeurogesX Completes Enrollment in Confirmatory Phase 3 Clinical Trial for Painful HIV Distal Sensory Polyneuropathy
8. Knopp Neurosciences Initiates Phase 1 Clinical Trial of KNS-760704 in ALS Development Program
9. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
10. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
11. Knopp Neurosciences Receives Orphan Designation for KNS-760704 for Treatment of ALS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
(Date:6/23/2016)... Ill. and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment ... Astellas Farma Brasil as the company,s second affiliate in Latin America . ... ... General Manager of Astellas Farma Colombia ... ...
(Date:6/23/2016)... , June 23, 2016 ... "Surgical Procedure Volumes: Global Analysis (United States, China, ... Canada)" report to their offering. ... essential tool for healthcare business planners, provides surgical procedure ... at surgery trends with an in-depth analysis of growth ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/27/2016)... ... 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy ... in the United States and Canada wear eyeglasses. Once considered to be a purely ... make a fashion statement. Even celebrities use glasses as a way of creating an ...
(Date:6/26/2016)... ... , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment center ... Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This annual ... the world’s leading providers of cereal and other breakfast foods. Its residents often refer ...
(Date:6/26/2016)... ... 2016 , ... PawPaws brand pet supplements owned by Whole Health ... the health of felines. The formula is all-natural and is made from Chinese herbs ... Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
Breaking Medicine News(10 mins):